Pink Hope Education Webinar -
What is HRD testing and how is it different to genetic testing?
ABOUT THE WEBINAR
This webinar will provide attendees with information about HRD testing for patients with ovarian cancer. Our expert panel will delve into some background on the different types of ovarian cancer, HRD testing, why it’s important and the difference between testing tumours and testing blood for gene abnormalities. You’ll learn the ins and outs of both somatic tumour testing and germline testing for gene mutations and most importantly, you’ll hear from a patient who will share their experience with ovarian cancer and HRD testing. You will have the opportunity to ask questions and if you can’t attend on the night, we’ll send you a recording so you can watch it later.
THE HOSTS
A/Prof Heather Thorne (OAM), researcher: Heather Thorne OAM is the national manager of kConFab, which brings together geneticists, clinicians, surgeon, genetic counsellors, psychosocial researchers, pathologists and epidemiologists, from Australia and New Zealand.
Prof Paul Cohen, gynaecologist, oncologist: Paul Cohen is a consultant at the Western Australian Gynaecological Cancer Service, King Edward Memorial Hospital in Perth, Clinical Professor in the Division of Obstetrics and Gynaecology, Medical School, University of Western Australia, and Adjunct Professor at the Institute for Health Research, University of Notre Dame Australia. Paul’s research interests include patient-reported outcomes and the supportive care of patients affected by gynaecological malignancies, gynaecological cancer genetics, the epidemiology of gynaecological malignancies, and biomarkers to predict histological tumour regression in women with high-grade serous tubo-ovarian cancer following neoadjuvant chemotherapy. Paul is the current chair of the International Gynecological Cancer Society (IGCS) Education Committee, and the Australia and New Zealand Gynaecological Oncology Group (ANZGOG) Research Advisory Committee, and a Board Director of ANZGOG and the IGCS.
Dr Cathy Kiraly-Borri, Clinical Geneticist: Dr. Cathy Kiraly-Borri is a seasoned clinician in public and private genetics, boasting over 20 years of expertise in various genetic consultation domains. Her specialisation lies in Paediatric onco-genetics and Familial Cancer.
Robyn Smith, Programs Manager: Robyn is the programs manager at Pink Hope. She has background in finance and health promotion and is a keen advocate for patients making informed decisions about managing their cancer risk.
